According to the research report titled ‘Implantable Medical Devices Market Size By Product, By Type (Diagnostic, Treatment), By Nature of Device (Active, Static/Non-active/Passive), By End-use (Hospitals, Multi-specialty Centres, Ambulatory Surgical Centers, Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, global implantable medical devices market is estimated to be worth USD 138.5 billion by the year 2025.
 

Rising incidence of chronic diseases, shortage of organ donors, and growing focus on development of microelectronics & implantable sensors are key factors driving global implantable medical devices market expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2483990/
 

Moreover, technological developments, rising government funding for implantable medical devices in developed countries, and increasing adoption of biomaterials for better biocompatibility & outcomes will aid industry growth.
 

On the other hand, high cost of devices, coupled with concerns over post procedural complications will act as challenges for industry partakers.
 

Based on product gamut, cardiovascular segment held 26% of the industry share in 2018. Rising occurrence of cardiovascular diseases, growing product awareness among people, and surging investment by government to improve healthcare facilities are promoting the expansion of this segment.
 

Speaking of type, therapeutic sector of global implantable medical devices industry was assessed at USD 89 billion in 2018.  Notably, these devices are used to heal injuries or disorders. Favorable reimbursement policies, prevalence of road accidents, and increasing incidences of organ failure caused by high obesity rates are aiding the segmental growth.
 

Considering nature of device, static/non active/ passive segment held 76% industry share in 2018, backed by efforts taken by the known leaders to develop new technologies and expand their product range.
 

Moving on to end user spectrum, the hospitals segment is anticipated to generate significant revenues between 2019-2025, owing to presence of specialized doctors, advanced healthcare facilities, and availability of modern devices.
 

From the geographical frame of reference, India implantable medical devices market is projected to record 10.3% CAGR over the assessment period, mainly due to presence of leading players, ever-increasing number of road accidents, and rising awareness about medical implants among the populace.
 

Key players profiled in the report are Biotronik SE & Co. KG, Medtronic plc, Henry Schein Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Allergan plc, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., W.L. Gore & Associates Inc., Stryker Corporation, Cochlear Limited, Boston Scientific Corporation, Intersect ENT Inc., Abbott Laboratories, Demant A/S, Alcon Inc., Nuvectra Corporation, Bausch & Lomb Inc ., Polytech Health & Aesthetics GmbH, and Getinge AB.